Drug intelligence / Profile preview

CRA_11092

Development stage: Unknown
Modality: Small Molecules

Overview

CRA_11092 is a small molecule compound belonging to the class of organic compounds known as phenylbenzimidazoles. These are characterized by the presence of a benzimidazole ring system substituted with a phenyl group. The chemical formula for CRA_11092 is C21H23FN4O2. Detailed information about its mechanism of action, clinical indications, or development status is not available in public sources[1][2][9].

Beyond the preview

Go deeper on CRA_11092.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRA_11092.

Explore the full profile